Hepatobiliary and Pancreatic: Nivolumab-related cholangiopathy

MeSH terms

• Aged
• Antineoplastic Agents, Immunological / adverse effects*
• Bile Ducts, Intrahepatic / diagnostic imaging*
• Bile Ducts, Intrahepatic / pathology*
• Carcinoma, Non-Small-Cell Lung / therapy
• Cholangiopancreatography, Magnetic Resonance*
• Cholangitis / chemically induced*
• Cholangitis / diagnostic imaging*
• Cholangitis / pathology*
• Humans
• Immunotherapy / adverse effects
• Lung Neoplasms / therapy
• Male
• Nivolumab / adverse effects*